Publications

5808 Results

Prostate specific antigen progression (PSA-P) as a predictor of overall survival (OS) in patients (pts) with metastatic prostate cancer (PC): data from S9346 and S9916

Authors
B Goldman;M Hussain;C Tangen;C Higano;DP Petrylak;N Vogelzang;ED Crawford
Journal / Conference
Proceedings of the American Society of Clinical Oncology 2008 Genitourinary Cancers Symposium, abst. 165
Year
2008
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9346, S9916

Pharmacogenetic analysis of stage II/III rectal cancer patients treated with 5-fluorouracil and pelvic radiation in a phase III intergroup trial (INT-0144, SWOG 9304)

Authors
W Zhang;C Rankin;F Nagashima;CM Ulrich;RS Holmes;KW Makar;JK Benedetti;CD Blanke;SR Smalley;HJ Lenz
Journal / Conference
American Society of Clinical Oncology 2008 Gastrointestinal Cancers Symposium, abst. 300
Year
2008
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9304 (INT-0144)

Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among stage II or III rectal cancer patients (SWOG 9304)

Authors
CM Ulrich;C Rankin;RS Holmes;KW Makar;JK Benedetti;SR Smalley;CD Blanke;HJ Lenz
Journal / Conference
American Society of Clinical Oncology 2008 Gastrointestinal Cancers Symposium, abst. 309, p. 223
Year
2008
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9304 (INT-0144)

Adjuvant radiotherapy for pT3 for prostate cancer: results of a randomized, prospective clinical trial, 2008 update

Authors
GP Swanson;IM Thompson;C Tangen;JC Paradelo;ED Canby-Hagino;ED Crawford;F Miller;MS Lucia;JD Forman;J Chin;EM Messing
Journal / Conference
American Urological Assn Annual Meeting, "late breaking" presentation
Year
2008
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8794

S0536 SWOG phase II trial of carboplatin (c), paclitaxel (P), cetuximab (CX) and bevacizumab (B) followed by cetuximab and bevacizumab in advanced non-small cell lung cancer (NSCLC)

Authors
ES Kim;RS Herbst;J Moon;J Crowley;M Redman;SR Dakhil;JL Wade;K Kelly;GR Gandara
Journal / Conference
Journal of Thoracic Oncology 3(11) supp. 4:S266, abst. #9
Year
2008
Research Committee(s)
Lung
Study Number(s)
S0536

Identification of genes with abnormal expression changes in acute myeloid leukemia

Authors
DL Stirewalt;S Meshinchi;KJ Kopecky;W Fan;EL Pogosova-Agadjanyan;JH Engel;MR Cronk;KS Dorcy;AR McQuary;D Hockenberry;B Wood;S Heimfeld
Journal / Conference
Genes Chromosomes Cancer 47(1):8-20
Year
2008
Research Committee(s)
Leukemia
PMID
PMID17910043

A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group study 0338 [PMID19073506]

Authors
HK Chew;WE Barlow;KS Albain;D Lew;AM Gown;DF Hayes;J Gralow;GN Hortobagyi;R Livingston
Journal / Conference
Clinical Breast Cancer 8(6):511-515
Year
2008
Research Committee(s)
Breast
Study Number(s)
S0338

Molecular epidemiology to better predict lung cancer risk

Authors
M Reid;RM Santella;CB Ambrosone
Journal / Conference
Clinical Lung Cancer 9(3):149-153
Year
2008
Research Committee(s)
Lung
PMID
PMID18621624
PMC
Review article not within scope of Public Access Policy
Study Number(s)
S0424

Bridging the gap between populations: the challenge of reducing cancer disparities among African Americans and other racial/ethnic minority populations

Authors
SD Williams-Brown;ED Cook;K Anderson;SJ Hamilton
Journal / Conference
US Oncology 4(1):72-75
Year
2008
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
NO PMID AVAILABLE
PMC
NO PMC AVAILABLE
Study Number(s)
S0000

Reply to correspondence, JCO/2008/184218, "SWOG S0023: what meets the eye may be only half the truth" [PMID18779597]

Authors
K Kelly;M Redman;DR Gandara
Journal / Conference
Journal of Clinical Oncology 26(29)4850-4851
Year
2008
Research Committee(s)
Lung
Study Number(s)
S0023